Targeted Approach to Distinguish and Determine Absolute Levels of GDF8 and GDF11 in Mouse Serum. Issue 11 (13th May 2020)

• Record Type: Journal Article
• Authors: Camparini, Luca; Kollipara, Laxmikanth; Sinagra, Gianfranco; Loffredo, Francesco S.; Sickmann, Albert; Shevchuk, Olga
• Other Names: Coman Cristina guestEditor.; Ahrends Robert guestEditor.
• Is Part Of: Proteomics. Volume 20:Issue 11(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-05-13
• Subjects: aging -- GDF11 -- immunoprecipitation -- myostatin/GDF8 -- serum -- targeted‐quantitative proteomics; Proteins -- Separation -- Periodicals; Bioinformatics -- Periodicals; Proteomics -- Periodicals; Genomes -- Periodicals; Molecular genetics -- Periodicals; 572.605
• DOI: 10.1002/pmic.201900104
• Languages: English
• ISSNs: 1615-9853

Abstract

Abstract: Growth differentiation factor 11 (GDF11) is a TGF‐β superfamily circulating factor that regulates cardiomyocyte size in rodents, sharing 90% amino acid sequence identity in the active domains with myostatin (GDF8)—the major determinant of skeletal muscle mass. Conflicting data on age‐related changes in circulating levels have been reported mainly due to the lack of specific detection methods. More recently, liquid chromatography tandem mass spectrometry (LC‐MS/MS) based assay showed that the circulating levels of GDF11 do not change significantly throughout human lifespan, but GDF8 levels decrease with aging in men. Here a novel detection method is demonstrated based on parallel reaction monitoring LC‐MS/MS assay combined with immunoprecipitation to reliably distinguish GDF11 and GDF8 as well as determine their endogenous levels in mouse serum. The data indicate that both GDF11 and GDF8 circulating levels significantly decline with aging in female mice.